晚期喉癌生物选择治疗中肿瘤浸润淋巴细胞的作用
本研究回顾性纳入76例接受生物选择治疗的晚期喉鳞状细胞癌患者,按CD8 TIL中位计数分为高/低两组。控制吸烟、肿瘤部位和分期后,高CD8 TIL计数是5年疾病特异性生存改善的独立预测因子(HR 0.17,95%CI 0.03-0.84,P=0.03),但CD8 TIL计数不能预测诱导化疗反应;
要点
- 高CD8 TIL计数与晚期喉癌生物选择患者5年疾病特异性生存改善独立相关。
- CD8 TIL计数不能预测诱导化疗反应,但与放化疗反应程度显著相关。
- 治疗前评估肿瘤浸润CD8细胞可能有助于筛选适合生物选择方案的患者。
核心结论
- 高CD8 TIL计数是接受生物选择治疗的晚期喉鳞癌患者5年疾病特异性生存改善的独立预测因子。
- CD8 TIL计数与诱导化疗反应无关,但与放化疗后的反应程度显著相关。
研究设计与样本
- 回顾性研究,纳入76例接受生物选择治疗且有可用组织的晚期喉鳞状细胞癌患者。
- 按CD8 TIL中位计数将患者分为CD8低和CD8高两组,采用Kaplan-Meier生存分析和多因素Cox回归(SPSS 26)。
主要发现
- 控制吸烟、肿瘤部位和分期后,高CD8 TIL计数是5年疾病特异性生存改善的独立预测因子(HR 0.17,95%CI 0.03-0.84,P=0.03)。
- CD8 TIL计数不能预测诱导化疗反应。
临床怎么用
- 治疗前评估肿瘤浸润CD8细胞可能有助于筛选适合生物选择方案的患者。
- CD8 TIL计数或可作为晚期喉癌患者预后分层和个体化治疗选择的参考指标。
局限性
- 回顾性研究设计,样本量有限(N=76),结果需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Bioselection to assess tumor response after induction chemotherapy has been introduced as an alternative treatment strategy to total laryngectomy for patients with advanced larynx squamous cell carcinoma (LSCC). Tumor-infiltrating lymphocytes (TILs) have proven to serve as prognostic biomarkers in head and neck cancer but have not been evaluated as a way to select patients for treatment paradigms. The aim of this study is to evaluate the role of pretreatment TILs in patients with advanced LSCC undergoing the bioselection paradigm. STUDY DESIGN: Retrospective study. SETTING: Tertiary care hospital. METHODS: Patients with advanced LSCC treated with bioselection and available tissue were included (N = 76). Patients were stratified into CD8-low and CD8-high cohorts by using the median TIL count. Kaplan-Meier survival analysis and multivariate cox regression were performed with SPSS version 26 (IBM). RESULTS: After controlling for tobacco use, tumor site, and stage, a high CD8 TIL count was an independent predictor of improved 5-year disease-specific survival (hazard ratio, 0.17 [95% CI, 0.03-0.84]; P = .03). CD8 TIL counts did not predict response to induction chemotherapy; however, subgroup analysis of patients treated with chemoradiation therapy revealed that CD8 TIL count was significantly associated with degree of response (P = .012). CONCLUSION: These findings support prior data published by our group showing that TILs are predictive of disease-specific survival in patients with head and neck cancer. CD8 TIL counts were significantly associated with degree of clinical response after induction chemotherapy. These results suggest that pretreatment assessment of tumor-infiltrating CD8 cells could be useful in selecting patients.
引用
- Heft Neal ME, Smith JD, Birkeland AC, et al. Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection. Otolaryngol Head Neck Surg. 2021. PMID: 34030495. doi:10.1177/01945998211013765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。